Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives
International Journal of Molecular Sciences · 12.06.2025 · 26 (12) · 5644
DOI: 10.3390/ijms26125644 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.06.2025. Verfasst von Emilia Kucharczyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wroclaw Medical University, Wybrzeże L. Pasteura 1, 50-367 Wroclaw, Poland. Hauptthemen laut MEDLINE: Warts, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Cutaneous warts caused by human papillomavirus (HPV) are among the most common dermatological conditions, affecting the quality of life of numerous people. Although they are widespread, effective and reliable treatment alternatives are limited, emphasizing the necessity for novel treatment options. Intralesional immunotherapy has emerged as a promising alternative, aiming to stimulate the host immune response to achieve the clearance of both treated and distant lesions. This review explores the immunopathogenesis of cutaneous warts and provides an in-depth analysis of intralesional therapies including measles–mumps–rubella (MMR) vaccine, purified protein derivative (PPD), Bacillus Calmette–Guérin (BCG), Candida antigen, Mycobacterium w vaccine (MWV), vitamin D3, and autoinoculation. We provide a comprehensive analysis of the most promising modalities, highlighting their mechanism of action, outcomes, advantages, and limitations. Although initial data indicate that intralesional immunotherapy offers advantageous efficacy and tolerability, there is a lack of standardized treatment protocols and randomized controlled trials to endorse its broad application. Nevertheless, considering its potential to address local and distant lesions with minimal adverse effects, intralesional immunotherapy may represent a transformative approach to managing cutaneous warts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Wroclaw Medical University, Wybrzeże L. Pasteura 1, 50-367 Wroclaw, Poland.
- Clinical Department of General Dermatology, Centre of General Dermatology Oncodermatology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
ORCID-Profile: Emilia Kucharczyk, Karolina Pawłuszkiewicz
Förderung
- Wroclaw Medical University
Zitieren
APA
Kucharczyk, E., Pawłuszkiewicz, K., Biliński, K., Maj, J., & Ponikowska, M. (2025). Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives. International Journal of Molecular Sciences, 26(12), 5644. https://doi.org/10.3390/ijms26125644
Vancouver
Kucharczyk E, Pawłuszkiewicz K, Biliński K, Maj J, Ponikowska M. Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives. International Journal of Molecular Sciences. 2025;26(12):5644. doi:10.3390/ijms26125644
BibTeX
@article{Kucharczyk2025,
author = {Kucharczyk, Emilia and Pawłuszkiewicz, Karolina and Biliński, Karol and Maj, Joanna and Ponikowska, Małgorzata},
title = {Intralesional Immunotherapy for Non-Genital Viral Warts: A Review of Current Evidence and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {12},
pages = {5644},
doi = {10.3390/ijms26125644}
}
EUVIMED